173 related articles for article (PubMed ID: 22096581)
1. Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.
Shu XH; Li H; Sun XX; Wang Q; Sun Z; Wu ML; Chen XY; Li C; Kong QY; Liu J
PLoS One; 2011; 6(11):e27484. PubMed ID: 22096581
[TBL] [Abstract][Full Text] [Related]
2. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
3. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.
Sun Z; Shi S; Li H; Shu XH; Chen XY; Kong QY; Liu J
Cancer Chemother Pharmacol; 2013 Nov; 72(5):965-73. PubMed ID: 23989725
[TBL] [Abstract][Full Text] [Related]
5. Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.
Shu XH; Li H; Sun Z; Wu ML; Ma JX; Wang JM; Wang Q; Sun Y; Fu YS; Chen XY; Kong QY; Liu J
Biochem Pharmacol; 2010 May; 79(10):1516-25. PubMed ID: 20105429
[TBL] [Abstract][Full Text] [Related]
6. Distinct sulfonation activities in resveratrol-sensitive and resveratrol-insensitive human glioblastoma cells.
Sun Z; Li H; Shu XH; Shi H; Chen XY; Kong QY; Wu ML; Liu J
FEBS J; 2012 Jul; 279(13):2381-92. PubMed ID: 22540632
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J
Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012
[TBL] [Abstract][Full Text] [Related]
8. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation.
Wen S; Li H; Wu ML; Fan SH; Wang Q; Shu XH; Kong QY; Chen XY; Liu J
J Neurooncol; 2011 Aug; 104(1):169-77. PubMed ID: 21161674
[TBL] [Abstract][Full Text] [Related]
10. Suppression of STAT3 NH
Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
[TBL] [Abstract][Full Text] [Related]
11. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
[TBL] [Abstract][Full Text] [Related]
12. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
[TBL] [Abstract][Full Text] [Related]
13. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
[TBL] [Abstract][Full Text] [Related]
14. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
15. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
[TBL] [Abstract][Full Text] [Related]
16. Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.
Xue S; Xiao-Hong S; Lin S; Jie B; Li-Li W; Jia-Yao G; Shun S; Pei-Nan L; Mo-Li W; Qian W; Xiao-Yan C; Qing-You K; Peng Z; Hong L; Jia L
Oncotarget; 2016 Nov; 7(46):75790-75799. PubMed ID: 27716625
[TBL] [Abstract][Full Text] [Related]
17. Short-term resveratrol exposure causes in vitro and in vivo growth inhibition and apoptosis of bladder cancer cells.
Wu ML; Li H; Yu LJ; Chen XY; Kong QY; Song X; Shu XH; Liu J
PLoS One; 2014; 9(2):e89806. PubMed ID: 24587049
[TBL] [Abstract][Full Text] [Related]
18. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors.
Dabir S; Kluge A; Aziz MA; Houghton JA; Dowlati A
Cancer Biol Ther; 2011 Jul; 12(2):139-51. PubMed ID: 21532337
[TBL] [Abstract][Full Text] [Related]
19. PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway.
Li C; Wang R; Zhang Y; Hu C; Ma Q
Mol Med; 2021 Nov; 27(1):150. PubMed ID: 34837964
[TBL] [Abstract][Full Text] [Related]
20. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
